ArticleCancer biology & therapy2014

Vemurafenib and panitumumab combination tailored therapy in BRAF-mutated metastatic colorectal cancer: a case report.

Carlo Capalbo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.